Minimal CD5 expression was observed in keratinocytes, fibroblasts, myeloid cells, or other non-T-cell compartments, supporting the specificity of CD5 expression to the lymphocytic cells in CTCL, especially the CD4 T cells. The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.